Utilize este identificador para referenciar este registo:
|Título:||Enteric mucosa integrity in the presence of a preserved innate interleukin 22 compartment in HIV type 1-treated individuals.|
|Autor:||Fernandes, Susana M.|
Pires, Ana R.
Foxall, Russell B.
Sousa, Ana E.
|Palavras-chave:||Gut Associated Lymphoid Tissue|
|Editora:||Oxford University Press|
|Citação:||Mucosal IL-22 in HIV-1 Infection • JID •|
|Resumo:||Interleukin 22 (IL-22) is emerging as a key cytokine for gut epithelial homeostasis and mucosal repair. Gut disruption is a hallmark of human immunodeficiency virus (HIV) infection. Here, we investigated IL-22 production and gut mucosal integrity in HIV type 1 (HIV-1)-infected individuals receiving long-term antiretroviral therapy (ART).Methods. Biopsy specimens from 37 individuals who underwent colonoscopy primarily for cancer screening and from 17 HIV-1-infected and 20 healthy age-matched controls were assessed.Results. We found significant depletion of sigmoid IL-22-producing CD4+ T cells (T-helper type 22 [Th22] cells) even after prolonged ART, contrasting with the apparently normal compartments of regulatory and interleukin 17 (IL-17)-producing CD4+ T cells, as well as total mucosal CD4+ T cells. Despite the preferential Th22 cell depletion, IL-22 production by innate lymphoid cells (ILCs) was similar to that observed in HIV-1-seronegative subjects, and transcription of genes encoding molecules relevant for IL-22 production (ie, AHR, IL23, IL23R, IL1B, IL6, and TGFB1) was preserved. Remarkably, levels of transcripts of IL-22-target genes (ie, REG3G, DEFB4A, S100A9, MUC1, and MUC13) were unaltered, suggesting an adequate production of antimicrobial peptides and mucins. In agreement, enteric epithelial architecture was fully preserved.Conclusions. Despite the reduced Th22 cell subset, innate IL-22-mediated mechanisms, essential for sigmoid mucosa integrity, were fully operational in long-term-treated HIV-1-infected individuals. Our data highlight IL-22 production by ILCs as an important target for therapies aimed at facilitating human mucosal reconstitution.|
|Descrição:||© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.|
|Aparece nas colecções:||FM-LIC - Artigos em Revistas Internacionais|
IMM - Artigos em Revistas Internacionais
Ficheiros deste registo:
|Enteric-Mucosa-Integrity.pdf||1,37 MB||Adobe PDF||Ver/Abrir Acesso Restrito. Solicitar cópia ao autor!|
Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.